US signs $1bn deal for 100-million doses of J&J’s Covid-19 vaccine candidate
This is J&J's first deal to supply its investigational vaccine to a country
05 August 2020 - 16:57
New Jersey, US — The US government will pay Johnson & Johnson (J&J) more than $1bn for 100-million doses of its potential coronavirus vaccine, as it stocks up on vaccines and drugs in an attempt to tame the pandemic.
The latest contract is priced at roughly $10 per vaccine dose produced by J&J, or about $14.50 per dose, including a previous $456m the US government promised to J&J for vaccine development in March..
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.